12,091 Xylem Inc. $XYL Shares Sold by Redmond Asset Management LLC

Key Points

• Redmond Asset Management reduced its Xylem stake by 37.5%, selling 12,091 shares and retaining 20,159 shares valued at approximately $2.04 million. Institutional investors collectively own 87.96% of the company.
• Xylem’s stock opened at $88.31, near its 52-week low, after quarterly revenue fell 3% year over year to $2.20 billion and EPS of $1.44 narrowly missed estimates. Analysts nevertheless maintain a “Moderate Buy” consensus with a $122.31 average price target.
• Analyst sentiment has become more cautious, with JPMorgan downgrading Xylem to “neutral” and lowering its target to $90, while several firms also cut targets. The company paid a quarterly dividend of $0.43, equivalent to a 1.9% annualized yield.

Redmond Asset Management LLC cut its position in Xylem Inc. (NYSE:XYL - Free Report) by 37.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 20,159 shares of the industrial products company's stock after selling 12,091 shares during the quarter. Redmond Asset Management LLC's holdings in Xylem were worth $2,042,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in XYL. XXEC Inc. acquired a new position in Xylem during the second quarter worth approximately $850,841,000. BlackRock Inc. purchased a new stake in Xylem in the second quarter valued at approximately $2,959,730,000. State Street Corp boosted its holdings in shares of Xylem by 2.4% in the second quarter. State Street Corp now owns 11,444,669 shares of the industrial products company's stock valued at $1,352,874,000 after acquiring an additional 270,972 shares during the period. Swedbank AB boosted its holdings in shares of Xylem by 0.3% in the first quarter. Swedbank AB now owns 5,526,725 shares of the industrial products company's stock valued at $660,444,000 after acquiring an additional 18,759 shares during the period. Finally, Royal Bank of Canada boosted its holdings in shares of Xylem by 1.1% in the first quarter. Royal Bank of Canada now owns 4,763,241 shares of the industrial products company's stock valued at $569,207,000 after acquiring an additional 53,210 shares during the period. Hedge funds and other institutional investors own 87.96% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. BNP Paribas Exane lowered their target price on shares of Xylem from $145.00 to $135.00 and set an "outperform" rating on the stock in a research report on Wednesday. Barclays set a $104.00 price target on shares of Xylem in a research report on Wednesday. Robert W. Baird set a $123.00 price target on shares of Xylem in a research note on Wednesday. JPMorgan Chase & Co. downgraded shares of Xylem from an "overweight" rating to a "neutral" rating and lowered their price objective for the stock from $118.00 to $90.00 in a research report on Wednesday. Finally, Citigroup dropped their price objective on shares of Xylem from $148.00 to $130.00 and set a "buy" rating on the stock in a research note on Wednesday. Ten analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $122.31.

Xylem Stock Down 4.9%

Xylem stock opened at $88.31 on Thursday. Xylem Inc. has a twelve month low of $87.40 and a twelve month high of $154.27. The stock has a 50 day moving average of $105.98 and a two-hundred day moving average of $118.05. The company has a current ratio of 1.61, a quick ratio of 1.24 and a debt-to-equity ratio of 0.23. The stock has a market capitalization of $20.62 billion, a price-to-earnings ratio of 21.03, a PEG ratio of 1.75 and a beta of 1.00.

Xylem (NYSE:XYL - Get Free Report) last released its earnings results on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.45 by ($0.01). Xylem had a net margin of 11.15% and a return on equity of 11.77%. The company had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.28 billion. During the same period in the previous year, the firm posted $1.37 EPS. The company's revenue for the quarter was down 3.0% on a year-over-year basis. As a group, research analysts expect that Xylem Inc. will post 5.65 earnings per share for the current year.

Xylem Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 24th. Investors of record on Thursday, August 27th were given a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date was Thursday, August 27th. Xylem's dividend payout ratio (DPR) is 40.95%.

More Xylem News

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Despite the near-term concerns, Xylem reported adjusted earnings of $1.44 per share, up from $1.37 a year earlier, while orders increased approximately 10%. Several firms still see substantial longer-term upside: Citigroup maintained a “buy” rating with a $130 target, BNP Paribas Exane retained “outperform” at $135, and Oppenheimer kept “outperform” at $135. Citigroup analyst action
• Neutral Sentiment: Xylem plans portfolio divestitures and a segment restructuring, which could improve focus and efficiency over time but may create execution costs and disruption in the near term. Xylem restructuring article
• Negative Sentiment: Third-quarter revenue was $2.20 billion, about $80 million below expectations and down 3% year over year; adjusted EPS also narrowly missed consensus. Weakness in metering and project timing contributed to the shortfall. Xylem Q3 revenue miss
• Negative Sentiment: Management lowered its 2026 revenue and profit outlook and issued cautious fourth-quarter expectations, citing customer pullbacks and ongoing operational headwinds. The guidance cut prompted multiple target reductions, including RBC to $125, Stifel to $114, and JPMorgan to $90; JPMorgan also downgraded the stock to “underweight.” Xylem outlook reduction
• Negative Sentiment: Put-option purchases were unusually heavy, rising roughly 358% above average daily volume, signaling increased hedging or bearish speculation. In addition, Levi & Korsinsky announced an investigation into potential securities-law violations related to shareholder losses. Xylem investigation notice

About Xylem

Xylem Inc NYSE: XYL is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company's products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.